December 15, 2019

December 13, 2019

Subscribe to Latest Legal News and Analysis

Healthcare Innovation Centers and Collaboration [PODCAST]

Collaboration Through Innovation Centers

Healthcare is facing a time of transformation as regulators, providers and other stakeholders take action to improve care coordination and increase the use of technology to deliver care. Hospital and health system innovation centers are increasingly acting as the catalyst to fuel growth and expansion through technology and data. In this episode of the Collaborative Transformation podcast series, McDermott partners Kerrin Slattery and Krist Werling discuss:

  • Opportunities for innovation centers and other collaborative arrangements in healthcare

  • Top regulatory and compliance challenges innovators face and ways to navigate them

  • Organizational and cultural issues for healthcare leaders to consider when making innovation a strategic priority

  • Investment structures and unique due diligence concerns to address when designing or investing in innovative deals

  • Key considerations when executing cross-border transactions in healthcare and life sciences

© 2019 McDermott Will & Emery

TRENDING LEGAL ANALYSIS


About this Author

Kerrin Slattery, McDermott, Healthcare Attorney
Partner

Kerrin B. Slattery maintains a diverse transactional practice focused on the representation of hospitals and health systems, as well as other health industry providers and investors across the country.

Kerrin has significant experience in all aspects of health industry transactions, including mergers, acquisitions, affiliations, joint ventures and system restructurings involving nonprofit hospitals and health systems, academic medical centers, post-acute providers, large medical groups and other health care providers. She also advises health industry clients on...

312-984-7685
Kristian A. Werling, McDermott Will & Emery LLP, Biotech Attorney
Partner

Kristian Werling is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office.  He focuses his practice on representing medical technology manufacturers, biotechs, diagnostics manufacturers and distributors of medical products in transactional and regulatory matters.  Concomitant with his practice in the contemporary landscape of healthcare and life sciences is a related depth of experience in representing private equity and venture capital investors. In this capacity he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions, add-on acquisitions and divestitures, as well as provide ongoing legal services to portfolio companies. 

312-984-2157